Innovent Biologics Expands its Antibody Pipeline and Manufacturing Capabilities

News   Nov 19, 2012

 
Innovent Biologics Expands its Antibody Pipeline and Manufacturing Capabilities
 
 
 

RELATED ARTICLES

Mechanism Behind Inflammatory Response to Cytoplasmic DNA Identified

News

A team led by LMU‘s Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in mice.

READ MORE

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE